The details bedevil DCOR.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 17943149.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Calcium-free oral phosphorus binders were heralded as a striking new development for patients with chronic kidney disease, promising a reduction in morbidity and mortality from cardiovascular disease. Sevelamer hydrochloride was the first such drug introduced to the market. Dialysis Clinical Outcomes Revisited (DCOR) is an outcomes study on the effect of sevelamer compared with calcium-based phosphorus binders in dialysis patients. It does not show a clear superiority of one compound over the other.
Medical subject headings
- Cardiovascular Diseases
- Chelating Agents
- Kidney Diseases
- Polyamines
- Renal Dialysis